Publicacións en colaboración con investigadores/as de Hospital de Sant Pau i Santa Tecla (8)

2011

  1. Clinical utility of maraviroc

    Clinical Drug Investigation, Vol. 31, Núm. 8, pp. 527-542

2010

  1. El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620

2009

  1. The changing face of HIV/AIDS in treated patients

    Current HIV Research, Vol. 7, Núm. 4, pp. 365-377

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

  2. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 206-209

  3. Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: A multicentre pilot study

    HIV Medicine, Vol. 9, Núm. 7, pp. 508-513

2007

  1. Cost minimization analysis of the different combinations of nucleoside analog reverse transcriptase inhibitors associated with adverse events in HIV-1 infected patients

    Pharmacoeconomics - Spanish Research Articles, Vol. 4, Núm. 1, pp. 25-36

2006

  1. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

    AIDS, Vol. 20, Núm. 10, pp. 1407-1414